Vulvovaginal candidiasis (VVC) remains one of the most prevalent gynecological infections—affecting up to 7 5% of women at least once and 10–35% of Indian women of reproductive age . While Candida albicans continues to dominate, the increasing prevalence of non-albicans species (like C. glabrata and C. krusei) poses diagnostic and therapeutic challenges. The consensus by Gandhi et al.
highlights that accurate diagnosis using microscopy or culture is essential , as clinical signs alone are unreliable. Topical azoles remain first-line therapy in uncomplicated cases, but recurrent or complicated infections require prolonged or combination antifungal regimens. During pregnancy, only topical azoles are recommended, preferably after the first trimester. The study emphasizes the growing need for individualized management, improved diagnostic vigilance, and prevention strategies to reduce…
